Search

everythinglearnresearchcommunity

for

Search:↓

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

Human hair follicles can be used to create heart muscle cells.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Human dermal stem cells can become functional skin pigment cells.

Stem cells can be used to create long-lasting skin cells for treating pigment disorders.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Hair follicle stem cells can help repair spinal cord injuries and improve walking.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Xenobiotic-free progenitor cells improve wound healing and blood vessel formation.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Scientists identified a unique type of human skin stem cell that could help with tissue repair.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

NADPH oxidase 4 is key for stem cell activity and growth under low oxygen.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

HAP stem cells in hair follicles could help repair nerves and spinal cords.

Targeting Vδ1+T-cells may help treat alopecia areata.

Scientists have found a way to create hair follicles from human stem cells, which could potentially be used to treat hair loss.

The method successfully isolates hair follicle stem cells from mice for research.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.